BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33600869)

  • 21. Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities.
    Wang SA; Hasserjian RP
    Am J Clin Pathol; 2015 Jul; 144(1):44-60. PubMed ID: 26071461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revisiting erythroleukemia.
    Arber DA
    Curr Opin Hematol; 2017 Mar; 24(2):146-151. PubMed ID: 27875373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute leukemia with erythroid hyperplasia. Our experience on a series of cases with acute myeloid leukemia.
    Selicean EC; Paţiu M; Cucuianu A; Dima D; Dobreanu M
    Rom J Morphol Embryol; 2014; 55(1):23-7. PubMed ID: 24715161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A History and Current Understanding of Acute Erythroid Leukemia.
    Alexander C
    Clin Lymphoma Myeloma Leuk; 2023 Aug; 23(8):583-588. PubMed ID: 37246017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future.
    Liao Z; Li J; Wu J; Liu J; Sun S
    Curr Mol Med; 2021; 21(10):819-831. PubMed ID: 33475071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute erythroid leukemia: autopsy report of a rare disease.
    Ferreira CR; Lima FR; Goto EH; Kim EIM; Smeili LAA; de Campos FPF; Zerbini MCN
    Autops Case Rep; 2011; 1(4):11-20. PubMed ID: 31528548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.
    Arenillas L; Calvo X; Luño E; Senent L; Alonso E; Ramos F; Ardanaz MT; Pedro C; Tormo M; Marco V; Montoro J; Díez-Campelo M; Brunet S; Arrizabalaga B; Xicoy B; Andreu R; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
    J Clin Oncol; 2016 Sep; 34(27):3284-92. PubMed ID: 27382099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum.
    Wong E; Juneja S
    Pathology; 2015 Jun; 47(4):289-93. PubMed ID: 25938365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response.
    Peng J; Hasserjian RP; Tang G; Patel KP; Goswami M; Jabbour EJ; Garcia-Manero G; Medeiros LJ; Wang SA
    Leuk Lymphoma; 2016; 57(4):812-9. PubMed ID: 26293512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
    Takeda J; Yoshida K; Nakagawa MM; Nannya Y; Yoda A; Saiki R; Ochi Y; Zhao L; Okuda R; Qi X; Mori T; Kon A; Chiba K; Tanaka H; Shiraishi Y; Kuo MC; Kerr CM; Nagata Y; Morishita D; Hiramoto N; Hangaishi A; Nakazawa H; Ishiyama K; Miyano S; Chiba S; Miyazaki Y; Kitano T; Usuki K; Sezaki N; Tsurumi H; Miyawaki S; Maciejewski JP; Ishikawa T; Ohyashiki K; Ganser A; Heuser M; Thol F; Shih LY; Takaori-Kondo A; Makishima H; Ogawa S
    Blood Cancer Discov; 2022 Sep; 3(5):410-427. PubMed ID: 35839275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid Neoplasms.
    Bennett JM
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):607-609. PubMed ID: 27693133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
    Calvo X; Arenillas L; Luño E; Senent L; Arnan M; Ramos F; Ardanaz MT; Pedro C; Tormo M; Montoro J; Díez-Campelo M; Arrizabalaga B; Xicoy B; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
    Mod Pathol; 2016 Dec; 29(12):1541-1551. PubMed ID: 27562492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
    Lee WH; Lin CC; Tsai CH; Tien FM; Lo MY; Ni SC; Yao M; Tseng MH; Kuo YY; Liu MC; Tang JL; Sun HI; Chuang YK; Chou WC; Hou HA; Tien HF
    Am J Hematol; 2023 Mar; 98(3):398-407. PubMed ID: 36588411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of azacitidine on the response and prognosis of myelodysplastic syndrome and acute myeloid leukemia involving a bone marrow erythroblast frequency of >50.
    Uchida T; Hagihara M; Hua J; Inoue M
    Leuk Res; 2017 Feb; 53():35-38. PubMed ID: 28013105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes.
    Kwon A; Weinberg OK
    Clin Lab Med; 2023 Dec; 43(4):657-667. PubMed ID: 37865509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of the 5
    Lee C; Kim HN; Kwon JA; Yoon SY; Jeon MJ; Yu ES; Kim DS; Choi CW; Yoon J
    Ann Lab Med; 2023 Sep; 43(5):503-507. PubMed ID: 37080752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.
    Wong JJ; Lau KA; Pinello N; Rasko JE
    Cancer Sci; 2014 Nov; 105(11):1457-63. PubMed ID: 25220401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Nardi V; Hasserjian RP
    Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Sportoletti P; Sorcini D; Guzman AG; Reyes JM; Stella A; Marra A; Sartori S; Brunetti L; Rossi R; Papa BD; Adamo FM; Pianigiani G; Betti C; Scialdone A; Guarente V; Spinozzi G; Tini V; Martelli MP; Goodell MA; Falini B
    Leukemia; 2021 Jul; 35(7):1949-1963. PubMed ID: 33159179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.